Literature DB >> 3572364

Immunoblot analysis of the human antibody response to respiratory syncytial virus infection.

H B Gimenez, H M Keir, P Cash.   

Abstract

The protein specificities of the antibodies induced during natural respiratory syncytial (RS) virus infection in humans were investigated using immunoblotting of human sera against virus proteins resolved by gel electrophoresis. Sera from 33 patients, who had complement-fixing antibodies against RS virus, were analysed. All the patients showed a response against the virus nucleoprotein (VPN41) and glycoprotein (VGP48). Antibodies against the virus proteins GP90, VPP32, VPM27 and two proteins of molecular weights 24,800 and 23,700 were also demonstrated. The spectrum of protein specificities of the antibodies varied among patients. There was an increase in the level of antibody for these virus proteins between the acute and convalescent serum samples from five patients. The protein specificities of the IgG and IgM antibodies were determined for five patients; VPN41, VPP32 and VPM27 induced IgG and IgM in all of these sera. Two of the five patients had detectable IgG but not IgM antibodies against VGP48, whereas the remaining three sera had detectable VGP48-specific IgG and IgM antibodies.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3572364     DOI: 10.1099/0022-1317-68-5-1267

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  6 in total

Review 1.  Immunity to human and bovine respiratory syncytial virus.

Authors:  T G Kimman; F Westenbrink
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

2.  A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.

Authors:  Pierre-Louis Hervé; Mariam Raliou; Christiane Bourdieu; Catherine Dubuquoy; Agnès Petit-Camurdan; Nicolas Bertho; Jean-François Eléouët; Christophe Chevalier; Sabine Riffault
Journal:  J Virol       Date:  2013-10-23       Impact factor: 5.103

3.  Prevalence of antibodies against HEp-2 cell antigen in infants and children hospitalized with respiratory syncytial virus infection.

Authors:  J Forster; O Maier; J Löbbert; K Kaufmehl; H J Streckert; H Werchau
Journal:  Infection       Date:  1996 Nov-Dec       Impact factor: 3.553

4.  Monoclonal antibody-based capture enzyme immunoassays for specific serum immunoglobulin G (IgG), IgA, and IgM antibodies to respiratory syncytial virus.

Authors:  D D Erdman; L J Anderson
Journal:  J Clin Microbiol       Date:  1990-12       Impact factor: 5.948

5.  Antibody-dependent enhancement of respiratory syncytial virus infection by sera from young infants.

Authors:  C Osiowy; D Horne; R Anderson
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

6.  Immunoglobulin A antibody response to respiratory syncytial virus structural proteins in colostrum and milk.

Authors:  H Tsutsumi; T Honjo; K Nagai; Y Chiba; S Chiba; S Tsugawa
Journal:  J Clin Microbiol       Date:  1989-09       Impact factor: 5.948

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.